CHAPTER 13 Dementia assessment, diagnosis and giving the news
FRAMEWORK
The authors present a significant argument for the early diagnosis of dementia but do not suggest that wide screening programs are beneficial. Opportunistic age-related screening may be appropriate to provide a future baseline for subsequent assessment when and if the person presents with cognitive changes later. The authors suggest that mandatory cognitive assessment should be done on admission to hospital or residential aged care and where there are major transition points that affect the person’s ability to cope. The importance of a comprehensive history of the person’s lifestyle, abilities, reactions to change and the use of suitable assessment tools cannot be underestimated. A full medical examination of physical functioning, including the neurological system and comorbid treatable illnesses, should be undertaken. The use of diagnostic tests (e.g., X-ray, scans, blood tests) to exclude other health problems, and perhaps liver biopsy if alcoholism is suspected, may be useful. Diagnosis should be made by specialists and the outcomes fully disclosed and relayed to the person and their family in a sensitive manner with referral to support services as needed. [RN, SG]
Introduction
Australia, like the rest of the world, is an ageing society. In 2007, 13% of Australia’s population was aged over 65; by 2056 this will rise to between 23 to 25% (ABS 2008). Whilst it is likely that the trend to better health at a given older age may well continue for at least the younger cohort of older people, it is less clear that this will be the case for the old-old. Thus a substantial challenge to our society will be the management of ageing-associated chronic diseases and the minimisation of any resultant disability in older people. Whilst age alone is clearly not the only factor in the aetiology of dementia, the incidence of the predominant form (i.e. Alzheimer’s disease) is strongly age-associated, nearly doubling each five years from the age of 60 (Australian Institute of Health and Welfare [AIHW] 2007), so that for people older than 85 years the prevalence of dementia is estimated at 22.4% (AIHW 2007). Access Economics has estimated that there are in the order of 50 000 new cases of dementia each year in Australia (Access Economics 2005).
Dementia assessment
Is it worth doing and if so for whom?
In general, screening (detection in asymptomatic individuals) is not recommended in consensus guidelines (New South Wales Department of Health 2003; Scottish Intercollegiate Guidelines Network [SIGN] 2006). Dementia remains a clinical diagnosis and both in less experienced hands and early on in the disease process the false positive rate in any screening program is likely to be significant. Screening asymptomatic 65–74-year-olds is likely to yield a false positive rate in the order of 93% (New South Wales Department of Health 2003). A substantial false positive rate is likely to be associated with significant distress and would divert already insufficient early diagnostic resources away from areas where they could be better used.
However, limited screening could be undertaken in high risk individuals in some circumstances such as those with known risk factors and particularly when appropriate functional and clinical history is deficient by virtue of diminished ability to self-report, or lack of a competent or reliable informant. Candidates include: people with Down’s syndrome; older individuals with multiple probable risk factors such as vascular risk factors (including diabetes, hypertension and hyperlipidaemia); people with established central or peripheral vascular disease; smokers; and in those with known or suspected previous significant cognitive insults, including chronic or persistent episodic alcohol abuse and cerebral injuries. Whilst one may argue this pushes the boundary between screening and case finding, in practice such boundaries are indistinct.
The process of assessment
If the informant history suggests the presence of cognitive impairment, one should search for evidence of more generalised cognitive changes. The presence of a baseline established earlier can give an invaluable reference point for detecting any subsequent change, so routine assessment of cognition for individuals above a certain age (75 is recommended in the UK) may have future utility even when normal results are found. Use of a screening tool appropriate to the educational, cultural and linguistic attributes of the person to be assessed is preferable, particularly if formal or informal education is at a relatively lower level than the population’s aged-matched median, making comparisons between the case at hand and the ‘normal’ population more difficult.
All of the shorter portable cognitive screening tools share, to varying degrees, limitations at both upper and lower ends of their ranges with a ceiling effect evident at the upper end and non-linearity particularly at the lower end of the range. Again, for a screening test as part of a more comprehensive assessment, where limitations of simple screening tests were understood, and informant history was sought, this would be acceptable. Whilst earlier studies suggested screening tests to be somewhat interchangeable (Stuss et al 1996) more recent reviews suggest accuracy is sacrificed for brevity (Cullen et al 2007).
Cognitive assessment may not take very long when dementia is clear-cut. A Mini-Mental State Examination (MMSE) may be all that is required when the score is 12, for example. However, when the presence of dementia is equivocal, the symptoms atypical, or there are challenges in the assessment (for example, a lack of formal education or language other than that of the examiner spoken), more detailed instruments such as the Cambridge Cognitive Examination, ADAS-Cog or, more usefully when available, full neuropsychological assessment by an expert neuropsychologist, will be required.